Andang, Kent .

HRN: 28-80-65  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2026
CEFOTAXIME 500MG (VIAL)
04/09/2026
04/16/2026
IV
125mg
Q12
T/late Onset Neonatal Sepsis
Remove - Pending Acceptance
04/09/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
04/09/2026
04/16/2026
IV
12.5mg
Q24
T/late Onset Neonatal Sepsis
Remove - Pending Acceptance
04/09/2026
CEFTAZIDIME 1GM (VIAL)
04/09/2026
04/16/2026
IV
85mg
Q8hours
Neonatal Sepsis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: